Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
JCI Insight|July 17, 2025
Insights into absence of lymphoma despite fulminant Epstein-Barr virus infection in patients with XIAP deficiencyYizhe Sun, Janet Chou, Kevin D Dong, et al.Cell Reports|November 4, 2020
Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA EditingRyan J Marina, Kristopher W Brannan, Kevin D Dong, et al.Bioorganic & Medicinal Chemistry Letters|May 10, 2024
Discovery of a DCAF11-dependent cyanoacrylamide-containing covalent degrader of BET-proteinsGary Tin, Marko Cigler, Matthias Hinterndorfer, et al.Nature Communications|March 3, 2022
Crosstalk between CRISPR-Cas9 and the human transcriptomeAaron A Smargon, Assael A Madrigal, Brian A Yee, et al.Journal of Proteome Research|November 27, 2023
Adapting an Isobaric Tag-Labeled Yeast Peptide Standard to Develop Targeted Proteomics AssaysKevin D Dong, Ernst W Schmid, Ryan D Bomgarden, et al.ACS Chemical Biology|November 18, 2025
Enrichment-Free, Targeted Covalent Drug Discovery in Live CellsKevin D Dong, Qing Yu, Ka Yang, et al.Nature Methods|May 8, 2021
Robust single-cell discovery of RNA targets of RNA-binding proteins and ribosomesKristopher W Brannan, Isaac A Chaim, Ryan J Marina, et al.Nature Biotechnology|July 29, 2026
An AI-enabled structural atlas decodes kinase specificity across the human proteomeDavid R Vanderwall, Edward L Huttlin, Julian Mintseris, et al.Biorxiv : the Preprint Server for Biology|January 13, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemiasTravis J Fleming, Mateusz Antoszewski, Sander Lambo, et al.Blood|September 24, 2025
CEBPA repression by MECOM blocks differentiation to drive aggressive leukemiasTravis J Fleming, Mateusz Antoszewski, Sander Lambo, et al.Pageof 2